Clinical Trials Browser

Unknown × Interventional × Solid Tumor, Adult × Clear all

NCT06433726 2024-05-30

A Phase l Study of By101921, an Oral PARP7 Inhibitor, in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT04092673 2024-05-21

Zotatifin

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT06348290 2024-04-04

Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT06240767 2024-02-05

Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT06232863 2024-02-02

A Study of BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT05388487 2024-01-16

Tolerability and Safety of HF1K16 Injection in Patients With Refractory Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT06056323 2023-10-23

A Study of HB0045 Injection in Patients With Advanced Solid Tumors

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT06027346 2023-09-07

A Study of Bio-008 in Subjects With Advanced or Metastatic Solid Tumours

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT04053673 2023-03-28

Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT05759234 2023-03-08

A Study of HS248 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT05623891 2022-11-23

Safety Study of 177Lu-Anti-ED-B mAbs SPECT Imaging in Patients With ED-B Positive Solid Tumors

Phase EARLY_PHASE1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT04976218 2022-11-16

TGFβR-KO CAR-EGFR T Cells in Previously Treated Advanced EGFR-positive Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT05442996 2022-07-05

A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of HLX35 in Combination With HLX10 in Patients With Advanced or Metastatic Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT05252975 2022-02-23

IMPRESS

Phase NA Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT05060263 2021-09-29

A Study of of HOT1030 in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT04989010 2021-08-04

Safety Study of 89Zr-Anti-CLDN18.2 mAbs PET Imaging in Patients With CLDN18.2 Positive Solid Tumors

Phase NA Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT04971369 2021-07-27

Safety Study of 89Zr-NY001 PET Imaging in Patients

Phase NA Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT04977128 2021-07-26

89Zr-labeled KN035 PET Imaging in Patients With PD-L1 Positive Solid Tumors

Phase NA Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT04175899 2021-03-08

POCCP1

Phase NA Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT04169178 2020-05-01

Evaluate Safety, Tolerability and PK of HLX55 in Patients With Advanced Solid Tumors With Different cMET Status

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT03160833 2020-02-13

A Study of HMPL-453 in Patients With Advanced Solid Malignancies

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT03977766 2019-06-06

CPV2-0

Phase NA Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT03638804 2018-12-05

89Zr-KN035 PET Imaging in Patients With Advanced Solid Tumors

Phase NA Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT03747965 2018-11-20

Study of PD-1 Gene-knocked Out Mesothelin-directed CAR-T Cells With the Conditioning of PC in Mesothelin Positive Multiple Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT03398720 2018-01-12

Safety and Tolerability of HTI-1066 in Subjects With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT03030001 2017-01-24

PD-1 Antibody Expressing CAR T Cells for Mesothelin Positive Advanced Malignancies

Phase 1/2 Unknown

Other solid neoplasm

Solid Tumor, Adult